Mepolizumab for treating severe eosinophilic asthma

Final draft guidance

Final appraisal document (PDF 189 KB)

Committee papers (PDF 5.55 MB)

Final stakeholder list (PDF 157 KB)

Final scope (PDF 176 KB)

Equality impact assessment (Scoping) (PDF 124 KB)

Consultation document (PDF 176 KB)

Final appraisal document - TA431 (PDF 166 KB)

Committee papers (FAD) - TA431 (PDF 3.01 MB)

Public committee slides (FAD) - TA431 (PDF 1.11 MB)

Appraisal consultation document (PDF version) (ACD2) - TA431 (PDF 2.09 MB)

Committee papers (ACD2) - TA431 (PDF 234 KB)

Appraisal consultation document (PDF version) (ACD1) - TA431 (PDF 6.45 MB)